The DEA telemedicine rules are crucial in shaping the digital healthcare future. Recently, a temporary extension on telemedicine flexibility for controlled medications was introduced, sparking discussions on whether this should be a permanent change. This debate was a central theme during the DEA listening session, where various stakeholders voiced their opinions on telehealth regulations.

DEA Telemedicine Listening Session: What This Challenge Actually Means

Telemedicine /

The DEA’s recent listening session on telemedicine rules highlighted the debate on the future of digital healthcare. With temporary extensions on telemedicine flexibilities for controlled medications, the session explored whether these measures should become permanent.

DEA Telemedicine Listening Session: What This Challenge Actually Means Read More »